Gene Details: GALE
1 / 1
General Information
Gene Name: GALE (UDP-glucose 4-epimerase)
Synonym:
Short Names:
Alternative Names: Galactowaldenase;UDP-N-acetylgalactosamine 4-epimerase;UDP-N-acetylglucosamine 4-epimerase;UDP-galactose 4-epimerase;
Notes:
- Epimerizes glucose to galactose on the UDP-glucose sugar nucleotide.
- GALE impairment leads to the human disorder known as galactosemia III which is associated with impaired growth and cognitive deficiencies.
Description from Dr.Glyco-GPT:
Write a 100-350 word essay about the enzyme human GALE. Provide information related to enzyme: i) function, ii) reaction pathways, ii) Location, and iv) diseases. In writing include these four subheadings ### Function Human GALE (UDP-galactose-4'-epimerase) is an essential enzyme in the Leloir pathway, responsible for the interconversion of UDP-galactose and UDP-glucose. This reaction is crucial for galactose metabolism, as it enables the utilization of galactose from the diet by converting it into a form that can enter glycolysis. Additionally, GALE can interconvert UDP-N-acetylgalactosamine and UDP-N-acetylglucosamine, playing a role in the biosynthesis of glycoproteins and glycolipids. ### Reaction Pathways GALE catalyzes the reversible epimerization of UDP-galactose and UDP-glucose through a mechanism involving NAD+ as a cofactor. This reaction is a key step in the Leloir pathway, which converts galactose into glucose-1-phosphate for further metabolism. The enzyme also acts on UDP-N-acetylhexosamines, which are substrates in the synthesis of glycoproteins and glycolipids, thereby contributing to the regulation of glycosylation processes. ### Location GALE is localized in the cytoplasm, where it is involved in the metabolic processing of galactose and other sugars. Its activity ensures that cells can efficiently metabolize galactose and produce the necessary substrates for glycosylation. The enzyme operates as a homodimer, with each monomer containing an active site for catalysis. ### Diseases Deficiency in GALE activity leads to a condition known as type III galactosemia, also referred to as epimerase-deficiency galactosemia. This rare genetic disorder can manifest in two forms: a mild, peripheral form affecting only red blood cells, and a severe, generalized form affecting multiple tissues. Patients with severe GALE deficiency may experience symptoms such as liver dysfunction, cataracts, intellectual disability, and other complications if not managed with dietary restrictions. In summary, GALE is a critical enzyme in both galactose metabolism and glycosylation pathways. Its role in converting UDP-galactose to UDP-glucose is essential for energy production and glycan synthesis, with deficiencies leading to serious metabolic disorders.
Catalytic Activity

Reaction and Disease Links
KEGG: 2582
Transcript levels (Cell lines and Single cell data) URL
CRISPR-knockout

CRISPR-activation

CRISPR-inactivation

Top 10 TFs
TF | Score |
---|---|
TCF25 | 0.472989 |
SSU72 | 0.470296 |
UBE2I | 0.454720 |
NCOR1 | 0.452397 |
YY1 | 0.451054 |
SNRNP70 | 0.446565 |
ZNF207 | 0.445704 |
SUMO1 | 0.438074 |
GTF2A2 | 0.433890 |
NONO | 0.428944 |
Licensing: CC BY 4.0. You are fee to copy, redistribute, remix, transform and build upon this material for commercial
and non-commercial purposes, provided source of information is attributed/credited.